There are some very real things to figure out in making sure that you can prescribe these GLP-1s in a way that come with enough handholding to help you understand and manage the side effects and make all the behavioral lifestyle changes that you need to to make them be effective and sustainable
For someone losing 1520% of their body weight, this can mean significant muscle loss, with real consequences for metabolic health, mobility, and long-term outcomes
Particularly notable is the increased occurrence rate among this age group in conditions such as starvation ketosis acidosis, sensory abnormalities, and medullary thyroid carcinoma
Patients who used semaglutide for six months or longer may experience slower adaptation than those who stopped after eight weeks, because the body develops deeper metabolic adjustments to the medication's presence
Marston in the Eastern District of Pennsylvania, consolidates claims that GLP-1 drugs caused NAION non-arteritic anterior ischemic optic neuropathy, a sudden, painless form of vision loss sometimes called "eye stroke." A July 2024 study in JAMA Ophthalmology found that semaglutide users faced a 4.28x increased risk of NAION among diabetics and a 7.64x increased risk among weight-loss patients